Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images
2018 · Cell Reports · 1,000 citations
https://doi.org/10.1016/j.celrep.2018.03.086
K
Ki Y. Chung
Prisma Health(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
102
Papers
8.1K
Citations
27
h-index
37
i10-index
Ki Y. Chung is an academic researcher from Prisma Health. The author has contributed to research in topics: Colorectal Cancer Treatments and Studies & Cancer Immunotherapy and Biomarkers & Cancer-related Molecular Pathways. The author has an h-index of 27, co-authored 87 publications.
ORCID: 0000-0001-6586-2013Papers by this author
worksTrastuzumab deruxtecan (DS-8201) in patients with HER2-expressing metastatic colorectal cancer (DESTINY-CRC01): a multicentre, open-label, phase 2 trial
2021 · The Lancet Oncology · 396 citations
https://doi.org/10.1016/s1470-2045(21)00086-3
Phase I study of ABBV-428, a mesothelin-CD40 bispecific, in patients with advanced solid tumors
2021 · Journal for ImmunoTherapy of Cancer · 58 citations
https://doi.org/10.1136/jitc-2020-002015
A phase 1b study evaluating the safety and preliminary efficacy of berzosertib in combination with gemcitabine in patients with advanced non-small cell lung cancer
2021 · Lung Cancer · 33 citations
https://doi.org/10.1016/j.lungcan.2021.11.011
Tucatinib and trastuzumab in HER2-mutated metastatic breast cancer: a phase 2 basket trial
2025 · Nature Medicine · 15 citations
https://doi.org/10.1038/s41591-024-03462-0
Patient-Reported Outcomes for Low-Risk Ductal Carcinoma In Situ
2024 · JAMA Oncology · 12 citations
https://doi.org/10.1001/jamaoncol.2024.6556
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat